<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2465">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04385147</url>
  </required_header>
  <id_info>
    <org_study_id>Global-Endo-COVID</org_study_id>
    <nct_id>NCT04385147</nct_id>
  </id_info>
  <brief_title>Advanced Endoscopy During COVID-19</brief_title>
  <official_title>The Status of Advanced Endoscopy in the Era of COVID-19: a Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Al-Azhar University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helwan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Liver Institute, Egypt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Al-Azhar University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, investigators aim to explore the status of advanced endoscopy in different
      endoscopy units all over the world.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, investigators aim to explore the status of advanced endoscopy (endoscopic
      retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different
      endoscopy units all over the world, to report the characteristics of patients presented to
      these units and their procedure details.

      evaluate the validity of different GI societies recommendations applied in different GI
      endoscopy units on the prevention of SARS-CoV-2 nosocomial transmission and the overall
      impact of this recommendations on the service provided by each GI unit.

      Target audience:

      - Physicians performing advanced gastrointestinal endoscopies in different countries.

      Objectives:

        -  Primary objective:

           1- To explore the status of advanced endoscopy (endoscopic retrograde
           cholangiopancreatography and endoscopic ultrasound on a global level) in different
           endoscopy units all over the world, to report the characteristics of patients presented
           to these units and their procedure details.

        -  Secondary objectives:

             1. Effect of COVID-19 precautions on procedure time, procedure success, complications
                and patient outcomes

             2. Effect of COVID-19 on working time and staff number

      Process:

      A questionnaire containing advanced endoscopy procedure details in different countries will
      be distributed via emails. Responses will be collected in an online platform and data will be
      analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of advanced
      endoscopy practice in the studied countries.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 18, 2020</start_date>
  <completion_date type="Actual">July 5, 2020</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Age, gender, nationality</measure>
    <time_frame>3 months</time_frame>
    <description>Investigators will report the baseline demographic data (age, gender, nationality) of all patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Indication for procedure, status of SARS-CoV-2 infection</measure>
    <time_frame>3 months</time_frame>
    <description>Investigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complete blood count and liver functions tests</measure>
    <time_frame>3 months</time_frame>
    <description>Investigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>procedure related complications</measure>
    <time_frame>3 months</time_frame>
    <description>Investigators will report the procedure related complications.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of COVID-19 precautions on procedure time</measure>
    <time_frame>3 months</time_frame>
    <description>Investigators will report wether the precautions lead to increase timing of the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of COVID-19 precautions on staff number</measure>
    <time_frame>3 months</time_frame>
    <description>Investigators will report wether the precautions affected staff number (increased or decreased)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">670</enrollment>
  <condition>Cholangitis, Secondary Biliary</condition>
  <condition>Cholangiocarcinoma</condition>
  <condition>Obstructive Jaundice</condition>
  <condition>Pancreas Cancer</condition>
  <condition>COVID-19</condition>
  <condition>SARS-CoV-2</condition>
  <arm_group>
    <arm_group_label>ERCP</arm_group_label>
    <description>Patients who will have endoscopic retrograde cholangiopancreatography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EUS</arm_group_label>
    <description>Patients who will have endoscopic ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endoscopic management according to standard of care</intervention_name>
    <description>Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case</description>
    <arm_group_label>ERCP</arm_group_label>
    <arm_group_label>EUS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with digestive disorders referred for ERCP or EUS during the study period in
        the participating centers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients referred for ERCP or EUS during the study period

        Exclusion Criteria:

          -  Patients refusing to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kings County Hospital Center, Brooklyn, NY, USA</name>
      <address>
        <city>Albertson</city>
        <state>New York</state>
        <zip>11507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Al-Azhar Univerisity</name>
      <address>
        <city>Cairo</city>
        <zip>11651</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medicine Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>D-17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>2- Hospital Guillermo Kaelin De la Fuente - EsSalud</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>169856</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
    <country>Germany</country>
    <country>Peru</country>
    <country>Singapore</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 11, 2020</study_first_submitted>
  <study_first_submitted_qc>May 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Al-Azhar University</investigator_affiliation>
    <investigator_full_name>Mohamed Alboraie</investigator_full_name>
    <investigator_title>Lecturer of medicine and gastroenterology</investigator_title>
  </responsible_party>
  <keyword>Obstructive Jaundice</keyword>
  <keyword>Cholangitis</keyword>
  <keyword>Pancreas Cancer</keyword>
  <keyword>COVID-19</keyword>
  <keyword>SARS-CoV-2</keyword>
  <keyword>esophagogastroduodenoscopy</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Endoscopic retrograde cholangiopancreatography</keyword>
  <keyword>Endoscopic ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Cholangitis</mesh_term>
    <mesh_term>Liver Cirrhosis, Biliary</mesh_term>
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Jaundice, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Investigators may share data after first publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

